ALNAQ
Price:
$0.000001
Market Cap:
$0
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts. On September 2, 2022, Allena Pharmaceuticals, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.[Read more]
Industry
Biotechnology
IPO Date
2017-11-02
Stock Exchange
PNK
Ticker
ALNAQ
According to Allena Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -160.99%. This represents a change of 83.41% compared to the average of -87.78% of the last 4 quarters.
The mean historical ROE of Allena Pharmaceuticals, Inc. over the last ten years is -87.67%. The current -160.99% ROE has changed 83.63% with respect to the historical average. Over the past ten years (40 quarters), ALNAQ's ROE was at its highest in in the December 2021 quarter at 30.12%. The ROE was at its lowest in in the June 2022 quarter at -228.63%.
Average
-87.67%
Median
-72.08%
Minimum
-275.26%
Maximum
41.34%
Discovering the peaks and valleys of Allena Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 281.88%
Maximum Annual ROE = 41.34%
Minimum Annual Increase = -163.19%
Minimum Annual ROE = -275.26%
Year | ROE | Change |
---|---|---|
2021 | -176.78% | 21.47% |
2020 | -145.53% | -47.13% |
2019 | -275.26% | 281.88% |
2018 | -72.08% | 175.90% |
2017 | -26.13% | -163.19% |
2016 | 41.34% | 1.48% |
The current ROE of Allena Pharmaceuticals, Inc. (ALNAQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-199.19%
5-year avg
-139.16%
10-year avg
-87.67%
Allena Pharmaceuticals, Inc.’s ROE is less than Advanced Proteome Therapeutics Corporation (0%), greater than Cellectis S.A. (-76.69%), less than ChitogenX Inc. (27.19%), greater than Biotron Limited (-504.53%), less than Bioasis Technologies Inc. (0%), less than Scopus BioPharma Inc. (0%), less than Magenta Therapeutics, Inc. (911.69%), greater than Marizyme, Inc. (-14.27%), less than IMV Inc. (448.62%), less than Forward Pharma A/S (0%), less than null (0%), greater than null (-2.53%),
Company | ROE | Market cap |
---|---|---|
0% | $147.12K | |
-76.69% | $183.12M | |
27.19% | $423.96K | |
-504.53% | $11.30M | |
0% | $284.08K | |
0% | $12.63K | |
911.69% | $42.44M | |
-14.27% | $6.59M | |
448.62% | $117.00 | |
0% | $7.45M | |
0% | $0 | |
-2.53% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allena Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Allena Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Allena Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Allena Pharmaceuticals, Inc. (ALNAQ)?
What is the highest ROE for Allena Pharmaceuticals, Inc. (ALNAQ)?
What is the 3-year average ROE for Allena Pharmaceuticals, Inc. (ALNAQ)?
What is the 5-year average ROE for Allena Pharmaceuticals, Inc. (ALNAQ)?
How does the current ROE for Allena Pharmaceuticals, Inc. (ALNAQ) compare to its historical average?